Expeditors International OF Washington Inc - Current report filing (8-K)
2008年10月1日 - 3:22AM
Edgar (US Regulatory)
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant
to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report:
September 29, 2008
(Date of earliest event reported)
EXPEDITORS
INTERNATIONAL OF WASHINGTON, INC.
(Exact name of registrant as specified in its
charter)
Washington
|
|
000-13468
|
|
91-1069248
|
(State or other jurisdiction of
|
|
(Commission File No.)
|
|
(IRS Employer Identification Number)
|
incorporation or organization)
|
|
|
|
|
1015 Third Avenue, 12
th
Floor,
Seattle, Washington
|
|
98104
|
(Address of principal executive offices)
|
|
(Zip Code)
|
(206) 674-3400
(Registrants telephone number, including
area code)
N/A
(Former name or former address, if changed
since last report)
Check the appropriate box below if the Form 8-K filing is intended
to simultaneously satisfy the filing obligation of the registrant under any of
the following provisions:
o
Written communications pursuant to Rule 425
under the Securities Act (17 CFR 230.425)
o
Soliciting material pursuant to Rule 14a-12
under the Exchange Act (17 CFR 240.14a-12)
o
Pre-commencement communications pursuant to Rule 14d-2(b) under
the Exchange Act (17 CFR 240.14d-2(b))
o
Pre-commencement communications pursuant to Rule 13e-4(c) under
the Exchange Act (17 CFR 240.13e-4(c))
Item 5.02 Departure
of Directors or Principal Officers; Election of Directors; Appointment of
Principal Officers.
On
September 29, 2008, Expeditors International of Washington, Inc. (Expeditors)
announced that Bradley S. Powell, 48, be appointed as Expeditors Chief
Financial Officer of the Company effective October 1, 2008. A copy
of the press release announcing the appointment of Mr. Powell is filed
with this report as Exhibit 99.1.
Mr. Powell
has served as Chief Financial Officer of Eden BioScience Corporation, a
publicly-traded biotechnology company, since July 1998. Since December 15, 2006, and during a
brief interim from November 2001 to June 2002, he also served as
President of Eden BioScience Corporation.
He has acted as Secretary of Eden BioScience Corporation since June 2000.
Mr. Powell
will receive an annual base salary of $100,000 and will also be eligible to
participate in the Companys Executive Bonus Pool under the 2008 Executive
Incentive Compensation Plan in an amount to be allocated by the Compensation
Committee of the Board of Directors. In addition, Mr. Powell will
also be granted an option to purchase 5,000 shares from the 2008 Stock Option
Plan as of the close of business on October 1, 2008.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits
Exhibit No.
|
|
Description
|
|
|
|
99.1
|
|
Press
Release of Expeditors International of Washington, Inc., dated
September 29, 2008, reporting the appointment of a principal officer.
|
2
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934,
the Registrant has duly caused this report to be signed on its behalf by the
undersigned thereunto duly authorized.
EXPEDITORS INTERNATIONAL OF WASHINGTON, INC.
September 30, 2008
|
/s/ PETER J. ROSE
|
|
|
Peter J. Rose, Chairman and
|
|
|
Chief Executive Officer
|
|
|
|
|
|
|
|
September 30, 2008
|
/s/ R. JORDAN GATES
|
|
|
R. Jordan Gates, President and
|
|
|
Chief Operating Officer
|
|
3
INDEX TO EXHIBITS
Exhibit No.
|
|
Description
|
|
|
|
99.1
|
|
Press
Release of Expeditors International of Washington, Inc., dated
September 29, 2008, reporting the appointment of a principal officer.
|
4
Expeditors International... (NASDAQ:EXPD)
過去 株価チャート
から 6 2024 まで 7 2024
Expeditors International... (NASDAQ:EXPD)
過去 株価チャート
から 7 2023 まで 7 2024